Amphastar Pharmaceuticals... (AMPH)
36.72
-0.39 (-1.05%)
At close: Jan 28, 2025, 1:41 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | 137.54M | 91.39M | 63.30M | 1.10M | 46.51M | -6.66M | 4.51M | 10.53M | -2.79M | -10.70M | 11.86M | 18.09M | 7.75M |
| Depreciation & Amortization | 41.78M | 28.74M | 26.75M | 25.18M | 21.12M | 16.52M | 15.44M | 14.56M | 13.25M | 14.45M | 13.08M | 11.50M | 11.15M |
| Stock-Based Compensation | 20.24M | 17.86M | 18.69M | 20.50M | 17.30M | 16.68M | 17.09M | 15.12M | 12.81M | 9.28M | 7.04M | 7.42M | 8.04M |
| Other Working Capital | -9.64M | -9.56M | 8.72M | -972.00K | 591.00K | 5.22M | -16.65M | 4.46M | -770.00K | 2.34M | -720.00K | 228.00K | 9.84M |
| Other Non-Cash Items | 21.89M | -878.00K | -13.03M | 240.00K | 1.04M | 1.43M | -2.34M | 1.31M | 420.00K | 648.00K | 217.00K | 2.71M | 581.00K |
| Deferred Income Tax | -13.74M | -15.75M | 4.21M | 1.12M | 7.55M | -1.88M | 3.93M | -3.27M | -7.88M | -8.24M | 2.08M | 8.28M | -36.01M |
| Change in Working Capital | -24.21M | -32.18M | -1.92M | 9.13M | -51.75M | 12.10M | 582.00K | 297.00K | -5.14M | 15.62M | -3.23M | -49.65M | 27.58M |
| Operating Cash Flow | 183.50M | 89.18M | 97.99M | 57.27M | 41.76M | 38.19M | 39.21M | 38.56M | 10.68M | 21.05M | 31.04M | -1.65M | 19.10M |
| Capital Expenditures | -38.17M | -24.03M | -27.46M | -33.85M | -41.55M | -46.81M | -35.10M | -21.38M | -16.05M | -20.50M | -18.30M | -25.25M | -10.72M |
| Acquisitions | -506.41M | 421.00K | n/a | n/a | n/a | 4.64M | 2.00M | -12.46M | 51.00K | -18.35M | n/a | n/a | n/a |
| Purchase of Investments | -144.56M | -35.76M | -17.38M | -13.56M | -8.81M | -308.00K | -5.64M | -3.60M | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 38.62M | 27.97M | 18.77M | 12.41M | n/a | 91.00K | 3.65M | 3.08M | n/a | n/a | 513.00K | 810.00K | 185.00K |
| Other Investing Acitivies | 1.39M | -1.37M | -2.61M | -1.41M | -157.00K | 198.00K | -3.66M | -5.13M | -878.00K | -922.00K | -509.00K | -677.00K | -2.00K |
| Investing Cash Flow | -649.12M | -32.78M | -28.67M | -36.41M | -50.53M | -42.18M | -38.76M | -39.50M | -16.93M | -39.77M | -18.30M | -25.11M | -10.54M |
| Debt Repayment | 526.34M | -1.78M | 32.10M | -880.00K | -3.21M | 3.07M | 9.27M | -4.45M | -2.21M | -2.71M | -8.58M | 23.84M | -5.90M |
| Common Stock Repurchased | -58.14M | -39.91M | -28.87M | -24.43M | -22.29M | -25.05M | -30.75M | -9.91M | -9.87M | -734.00K | -199.00K | -811.00K | -1.75M |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -14.11M | 15.25M | -40.24M | 23.06M | 3.42M | 8.95M | 13.76M | 21.50M | 14.31M | 35.17M | -592.00K | 213.00K | -922.00K |
| Financial Cash Flow | 454.09M | -26.44M | -37.02M | -2.25M | -3.78M | 25.01M | -7.72M | 7.14M | 2.24M | 32.12M | -9.37M | 23.24M | -8.58M |
| Net Cash Flow | -11.80M | 29.75M | 32.08M | 18.96M | -12.65M | 20.74M | -6.76M | 6.28M | -1.75M | 14.24M | 3.37M | -3.52M | -15.00K |
| Free Cash Flow | 145.34M | 65.15M | 70.54M | 23.41M | 207.00K | -8.62M | 4.11M | 17.18M | -5.37M | 553.00K | 12.74M | -26.89M | 8.38M |